FluidAI Medical

FluidAI Medical announces an acquisition deal with Emmetros Limited

KITCHENER, ON, Nov. 26, 2025 /PRNewswire/ – FluidAI Medical, a medical technology company that develops novel hardware, software, and artificial intelligence (AI) solutions, today announced an acquisition deal with SparxConnect developer Emmetros Limited, a leading company in the patient engagement…

FluidAI Medical’s Origin™ device has received FDA 510(k) clearance, a pivotal milestone redefining the future of data-driven, post-operative care

In the news release, Fluid AI Medical Receives FDA 510(k) Clearance for Origin™, a Real-Time Postoperative Bedside Monitoring Device, issued 24-Sep-2025 by Fluid AI Medical over PR Newswire, we are advised by the company that the news release has been updated. The complete, updated release follows:…

FluidAI secures a $2-million government of Canada investment to accelerate global commercialization of AI-driven postoperative care technology

KITCHENER, ON, July 9, 2025 /CNW/ – On February, 12th, 2025, the Government of Canada announced $2 million in funding to FluidAI Medical (FluidAI) through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of a broader investment  aimed at supporting Waterloo…

A hospital network in Hamilton is tapping into artificial intelligence

Doctors with Hamilton Health Sciences are using the technology to protect patients from life-threatening complications after surgery. CTV’s Health Reporter Pauline Chan reports. The post A hospital network in Hamilton is tapping into artificial intelligence first appeared on FluidAI Medical .